Figure 4.
Difference of characteristics of breast cancer patients who did not have unique SNP in CD44 intron 1 (CD44 Ex2+14 A>G) and those that had heterozygous or homozygous unique SNP. The clinical characteristics included: (A) patient’s age at cancer diagnosis, (B) size of tumor at diagnosis, (C) number of regional metastatic lymph nodes involved when the patients were diagnosed with breast cancer, (D) patients who were never cancer free, and (E) patients having cancer recurrence.